A simple, stability-indicating micellar electrokinetic chromatography (MEKC) method was developed and validated for the analysis of mianserin hydrochloride in coated tablets. The method employed (hydroxymethyl)aminomethane (TRIS) 50 mM to which sodium dodecyl sulfate (SDS) 50 mM was added at pH 10.6 as the electrolyte and the voltage applied was 25 kV. The capillary used was 48.5 cm long (40.0 cm effective length and 50.0 µm i.d.) and the detection wavelength was 220 nm. Tetracycline was used as internal standard. The method was validated in accordance with the International Conference on Harmonization (ICH) requirements, which involved specificity, linearity, precision, accuracy and robustness. The stability-indicating capability of the method was established by enforced degradation studies combined with peak purity assessment using photodiode array detection. The degradation products formed under photolytic and oxidative conditions were investigated by electrospray ionization mass spectrometry. The method was linear over the concentration range of 50-130 µg/mL. The method was precise as demonstrated by an inter-day and intra-day relative standard deviation of less than 2.0%. The proposed validated MEKC method showed recoveries between 98.16 and 102.80% of the nominal contents. The Plackett-Burman design was applied for the robustness test in order to examine potential sources of variability by screening a large number of factors in a relatively small number of experiments.Key words capillary electrophoresis; mianserin hydrochloride; mass spectrometry Mianserin hydrochloride (Fig. 1) is a drug for the treatment of depressive illness and depression associated with anxiety. Its antidepressant effect is mainly attributed to presynaptic alfa2-adrenoreceptor blocking activity and to serotonin receptor antagonism. Mianserin is classified as an atypical antidepressant, based on its undefined action mechanism. 1)This drug is considered a weak base with two pK a values (2.7, 8.26) and chemically known as (RS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c, f ] pyrazino[1,2-α] azepine hydrochloride. In humans, its major metabolic pathways include 8-hydroxylation, N-demethylation, and N-oxidation catalyzed mainly by CYP2D6, and by CYP3A4 and 1A2.2) In rats, the additional metabolite, 8-hydroxy-N-desmethylmianserin is formed from 8-hydroxyminaserin and/or N-desmethylmianserin. 3)From the analytical point of view, methods for its determination in biological fluids [4][5][6] and dosage form 7) have been reported. However, none of the reported methods for the determination of mianserin hydrochloride was shown to be a stability-indicating. It was therefore important to develop and validate a capillary electrophoresis stability-indicating method for this major compound, that can be employed in stability studies and routine quality control of its preparations. In the literature were found three relevant publications on the determination of mianserin enantiomers by capillary electrophoresis (CE). [8][9][10] The use of CE in the pharm...
A new high-performance liquid chromatographic method was developed and validated for clopidogrel determination in pharmaceutical formulations. The system consisted of an ACE 5 octadecylsilane (C18; 150 4.6 mm id), 5.0 m particle size column; methanol0.1 triethylamine (75 + 25, v/v), pH 5.3, mobile phase at a flow rate of 1.2 mL/min; and a diode array detector set at 220 nm. Specificity, linearity, precision, accuracy, and robustness were the parameters evaluated. The retention time for clopidogrel was 6.8 min. To estimate specificity, an aqueous sample solution was subjected to degradation by ultraviolet light and by acid, alkaline, and oxidation media. The peaks of degradation products did not interfere with the compound signal, and there was no interference when a placebo solution was analyzed. Linearity over a concentration range of 10.0 to 90.0 g/mL was shown (correlation coefficient = 0.9998). Low values of relative standard deviation indicated the adequate intraday and interday precision. The average recovery was found as 99.16. In the robustness test, small modifications to the mobile phase composition did not affect the determination of clopidogrel. The proposed method proved to be simple, fast, and cost efficient for the intended use.
Rabeprazole sodium is an antisecretory agent that inhibits the enzyme H+/K+ ATPase present in the stomach parietal cells. There are few data about its quantitative determinations in laboratorial routines. Capillary electrophoresis is a method being used increasingly for analysis of pharmaceutical compounds, the main advantages of which are the simplicity of instrumentation, low consumption of sample and reagents, and fast analysis. The aim of this study was to develop and validate a capillary electrophoresis method for determination of rabeprazole sodium in coated tablets. The conditions used were a bare fused silica capillary with 48.0 cm length (39.5 cm effective) and 75 μm id; a 10mM, pH 9.0, sodium tetraborate run buffer; a diode array detector set at 291 nm; hydrodynamic injection (50 mbar/5 s); and a voltage of 20 kV. HP Chemstation CE rev. A.06.03 software was used for system control, data acquisition, and analysis. The method was demonstrated to be linear in the concentration range of 5.0–40.0 μg/mL (r = 0.9993), precise (interday relative standard deviation = 0.49), accurate (mean recovery = 103.1%), and specific. The limits of detection and quantitation were 1.29 and 3.91 μg/mL, respectively.
Tibolone is a drug used as a hormonal repository and is very important due to its characteristic of helping to reduce the symptoms triggered by the hormonal alteration during the climacteric period. Although widely used, the Brazilian Pharmacopoeia does not have any information about this hormone. In the literature, only studies with methodologies using high performance liquid chromatography for drug quantification were found. Thus, this study aimed to develop and validate analytical method using UV spectrophotometry for quality control of Tibolone in capsule pharmaceutical form. The present study followed the validation parameters present in RDC 166/2017 and ICH Q2 (R1), with acetonitrile as solvent and 225 nm as wavelength. Linearity showed a correlation coefficient higher than 0.99, precision presented a mean of 97.81% and accuracy reached a recovery percentage average of 97.18%. It was concluded that the method can be used in the quality control of Tibolone capsules, besides having a low cost and a less complex methodology and easier to perform compared to HPLC.
Ultraviolet spectrophotometric (UV) and Liquid Chromatographic (LC) methods for the determination of mianserin hydrochloride in pharmaceutical formulation were developed and validated. The various parameters, such as specificity, linearity, precision and accuracy were studied according to International Conference on Harmonization (ICH, 2005). For UV method, mianserin hydrochloride was determinate at 278 nm using HCl 0.1 M as the solvent. The response was linear in the concentration range of 20.0 -140.0 µg/mL (r = 0.9998). Precision data evaluated by relative standard deviation was lower than 2%. The UV method was simple, rapid and low cost. Chromatographic analyses were performed in an Ace C 18 column and the mobile phase was composed of methanol, 50 mM monobasic potassium phosphate buffer and 0.3% triethylamine solution adjusted to pH 7.0 with phosphoric acid 10% (85:15). LC method was specific, linear, precise, exact and robust. The results confirmed that the both methods are valid and useful to the routine quality control of mianserin hydrochloride in coated tablets. Statistical analysis by Student´s t-test showed no significant difference between the results obtained by UV and LC methods. Uniterms:Ultraviolet spectrophotometry/qualitative analysis. Liquid chromatographic/qualitative analysis. Mianserin hydrochloride/determination in tablets. Coated tablets/qualitative analysis.Os métodos por espectrofotometria na região do ultravioleta (UV) e por cromatografia líquida (CL) para determinação do cloridrato de mianserina na forma farmacêutica foram desenvolvidos e validados. Os vários parâmetros, como especificidade, linearidade, precisão e exatidão foram avaliados de acordo com o International Conference on Harmonization (ICH, 2005). Para o método de UV, o cloridrato de mianserina foi determinado utilizando o comprimento de onda de 278 nm e HCl 0,1 M como solvente. A resposta foi linear na faixa de concentração de 20,0 a 140,0 µg/Ml (r = 0,9998). A precisão foi avaliada pelo valor de desvio padrão relativo (DPR) inferior a 2%. O método por UV é simples, rápido e de baixo custo. As análises cromatográficas foram realizadas em uma coluna Ace C 18 e a fase móvel foi composta por metanol, tampão fosfato de potássio monobásico 50 mM com 0,3% de trietilamina com o pH ajustado para 7,0 com ácido fosfórico 10% (85:15). O método de CL foi específico, linear, preciso, exato e robusto. Os resultados confirmam que ambos os métodos são válidos e úteis para o controle de qualidade do cloridrato de mianserina em comprimidos revestidos. A análise estatística por teste t de Student não mostrou diferença significativa entre os resultados obtidos para os métodos de UV e CL.Unitermos: Espectrofotometria na região do ultravioleta/análise quantitativa. Cromatografia líquida/ análise quantitativa. Cloridrato de mianserina/determinação em comprimidos. Comprimidos revestidos/ análise qualitativa.
Todo o conteúdo deste livro está licenciado sob uma Licença de Atribuição Creative Commons. Atribuição 4.0 Internacional (CC BY 4.0).O conteúdo dos artigos e seus dados em sua forma, correção e confiabilidade são de responsabilidade exclusiva dos autores. Permitido o download da obra e o compartilhamento desde que sejam atribuídos créditos aos autores, mas sem a possibilidade de alterá-la de nenhuma forma ou utilizá-la para fins comerciais.
Sitagliptin phosphate is a drug used to treat diabetes mellitus type 2, and it belongs to a new therapeutic class called dipeptidyl peptidase IV inhibitors. This hypoglycemic drug is commercially available in coated tablets containing 25, 50, and 100 mg of sitagliptin base. The purpose of this study was to develop and validate the conditions for the dissolution test by investigating a possible in vivo-in vitro correlation. Several parameters were tested to develop the method, and the following conditions were considered satisfactory: pH 6.8 phosphate buffer, 900 mL of dissolution medium, temperature at 37 ± 1 °C, paddle apparatus, and rotation speed at 50 rpm. The dissolved percentage of STG was quantified by high performance liquid chromatography. The sink condition and specificity were determined in all media tested during method development. The parameters evaluated to validate the method were specificity, linearity, precision, and accuracy. The stability of the sample in phosphate buffer solutions for 24 h was also determined. The method is linear in the range of 10.0-70.0 µg/mL, precise, with RSD values less than 2%, and accurate (mean recovery 98.51%). The dissolution method as developed and validated supplied a good IVIVC when employing pH 6.8 phosphate buffer medium, which can be used in quality control of sitagliptin coated tablets since no official method has been described.
A dissolution test for mianserin hydrochloride in coated tablets containing 30 mg was developed and validated using a fast ultraviolet spectrophotometric method. The appropriate conditions were determinate after testing sink conditions, agitation spped and dissolution medium. The sink conditions tested showed that mianserin hydrochloride was soluble in 0.01 and 0.1 M hydrochloric acid (HCl), acetate buffer pH 4.1 and 5.0 and phosphate buffer pH 6.8. Then, dissolution tests were performed to investigate the drug release in each medium. Optimal conditions to carry out the dissolution test were 900 mL 0.1 M HCl and USP apparatus 2 (paddle) at 50 rpm stirring speed. The quantification method was also adapted and validated. The UV method showed specificity, linearity, precision and accuracy. The in vitro dissolution test can be used to evaluate the drug release profile and the data was used as an aid to establish a possible correlation with in vivo data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.